Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow Reinvestment Rate
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥35.55 Million (capex CN¥35.55 Million ) from operating cash flow of CN¥227.64 Million. Check 002020 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. Explore how much of Zhejiang Jingxin Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Jingxin Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | CN¥768.92 Million | CN¥781.35 Million | CN¥202.85 Million | ▼ -50.0% |
| 2024 | 1.97x | CN¥1.43 Billion | CN¥726.16 Million | CN¥250.65 Million | ▲ +29.1% |
| 2023 | 1.52x | CN¥1.26 Billion | CN¥824.69 Million | CN¥519.51 Million | ▲ +52.0% |
| 2022 | 1.00x | CN¥857.97 Million | CN¥855.78 Million | CN¥515.57 Million | ▼ -59.9% |
| 2021 | 2.50x | CN¥912.77 Million | CN¥365.02 Million | CN¥404.43 Million | ▲ +23.2% |
| 2020 | 2.03x | CN¥1.04 Billion | CN¥513.21 Million | CN¥334.00 Million | ▲ +196.3% |
| 2019 | 0.68x | CN¥366.65 Million | CN¥535.30 Million | CN¥337.33 Million | ▲ +45.5% |
| 2018 | 0.47x | CN¥246.39 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -86.4% |
| 2017 | 3.45x | CN¥1.33 Billion | CN¥385.01 Million | CN¥112.19 Million | ▲ +68.1% |
| 2016 | 2.05x | CN¥519.01 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +96.8% |
| 2015 | 1.04x | CN¥151.04 Million | CN¥144.69 Million | CN¥114.31 Million | ▲ +131.9% |
| 2014 | 0.45x | CN¥94.75 Million | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥108.28 Million | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥83.51 Million | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥71.86 Million | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥155.87 Million | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥20.18 Million | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥43.81 Million | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥134.67 Million | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥98.11 Million | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥71.19 Million | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥47.79 Million | CN¥45.50 Million | CN¥47.79 Million | — |